Prognostic value of pretreatment peripheral blood biomarkers in patients with head and neck squamous cell carcinoma treated with chemo/bioradiotherapy
Sansa, Aina (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT))
Vásquez, Rosselin (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Valero Mayor, Cristina (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Vázquez, Cristina (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Holgado, Anna (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Gayà, Júlia (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Rubio, David (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
León i Vintró, Xavier (Institut de Recerca Sant Pau)

Fecha:	2025
Resumen:	Purpose: Hematological parameters obtained from a pretreatment peripheral blood lab test, as well as indices calculated from these parameters, are associated with the prognosis of the disease in patients with head and neck squamous cell carcinomas (HNSCC). The aim of this study is to determine which of the parameters or indices would have the best prognostic ability in HNSCC patients treated with chemo-radiotherapy or bio-radiotherapy. Methods/patients: Retrospective study of 345 patients with HNSCC treated with chemo/bio-radiotherapy, for whom a pretreatment lab test was available. Results: Of the parameters and indices analyzed, the one with the best prognostic capacity was the Host-index (H-index), which combines the prognostic capacity of hemoglobin and albumin levels, along with the absolute counts of neutrophils, monocytes, and lymphocytes. This index was available for 309 patients. Based on a recursive partitioning analysis, three groups of patients were defined according to the H-index. Considering as reference the patients with an H-index lower than 1. 88 (n = 80, 25. 9%), patients with an H-index value between 1. 88 and 3. 62 (n = 115, 37. 2%) had a 2. 74 times higher risk of dying due to the tumor (95% CI 1. 41-5. 30, P = 0. 003), and patients with an H-index value greater than 3. 62 (n = 114, 36. 9%) had a 5. 62 times higher risk (95% CI 2. 95-10. 81, P = 0. 0001). Conclusion: The index derived from peripheral blood parameters that showed the best prognostic capacity in patients with head and neck squamous cell carcinoma treated with chemo/bio-radiotherapy was the H-index.
Nota:	Altres ajuts: acords transformatius de la UAB
Derechos:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Lengua:	Anglès
Documento:	Article ; recerca ; Versió publicada
Materia:	Biomarkers ; Head and neck squamous cell carcinoma ; Peripheral blood ; Host ; H-index
Publicado en:	Clinical & translational oncology, 2025 , ISSN 1699-3055

DOI: 10.1007/s12094-025-03897-y
PMID: 40323571

9 p, 627.1 KB

El registro aparece en las colecciones:
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Instituto de Investigación e Innovación Parc Taulí (I3PT)
Documentos de investigación > Documentos de los grupos de investigación de la UAB > Centros y grupos de investigación (producción científica) > Ciencias de la salud y biociencias > Institut de Recerca Sant Pau
Artículos > Artículos de investigación
Artículos > Artículos publicados